Nicholas B. Lydon
Nicholas B. Lydon (born February 27, 1957 ) is an American biochemist and businessman.
Life
Lydon earned a bachelor's degree in biochemistry and zoology from the University of Leeds in 1978 and a Ph.D. in biochemistry from the University of Dundee . From 1982 to 1985 he worked as a research assistant at Schering-Plow in Lyon and Paris , then until 1997 he was research group leader for tyrosine kinase inhibitors at Ciba-Geigy (now Novartis) in Basel . In 1997 he founded the pharmaceutical company Kinetix Pharmaceuticals in Boston , which he headed until 2000. Other biotechnology companies Lydon helped found include Granite Biopharma , AnaptysBio and Blueprint Medicines . He continues to hold a leading position at the latter two (as of 2012).
Act
Lydon is one of the developers of the tyrosine kinase inhibitors Imatinib (trade name Glivec) and Dasatinib (trade name Sprycel), which represent a new and successful active principle in the treatment of various tumors, especially leukemia .
Thomson Reuters has ranked Lydon as one of the favorites for a Nobel Prize in Physiology or Medicine ( Thomson Reuters Citation Laureates ) since 2011 .
Awards (selection)
- 2000 Warren Alpert Foundation Prize
- 2002 Kettering Prize from the General Motors Cancer Research Foundation
- 2009 Lasker ~ DeBakey Clinical Medical Research Award
- 2011 Honorary Doctorate (Law) from the University of Dundee
- 2012 Japan Prize
- 2013 member of the Royal Society
- 2013 GlaxoSmithKline Prize from the Royal Society
Individual evidence
- ↑ Nick Lydon, Ph.D., FRS at anaptysbio.com; accessed on February 13, 2016
- ^ Board of Directors at blueprintmedicines.com; accessed on February 13, 2016
- ↑ Nicholas B. Lydon at Thomson Reuters (thomsonreuters.com); Retrieved March 30, 2012
- ^ Lasker ~ DeBakey Clinical Medical Research Award - 2009 Winners at the Lasker Foundation (laskerfoundation.org); Retrieved March 30, 2012
- ↑ Nicholas B. Lydon, Ph.D. at the Japan Prize Foundation (japanprize.jp); Retrieved March 30, 2012
- ^ New Fellows 2013 of the Royal Society (royalsociety.org); Retrieved May 7, 2013
- ^ Royal Society GlaxoSmithKline Prize and Lecture at the Royal Society (royalsociety.org); Retrieved July 22, 2013
| personal data | |
|---|---|
| SURNAME | Lydon, Nicholas B. |
| ALTERNATIVE NAMES | Lydon, Nicholas |
| BRIEF DESCRIPTION | American biochemist and businessman |
| DATE OF BIRTH | February 27, 1957 |